These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

752 related items for PubMed ID: 25604900

  • 1. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
    Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ.
    Contraception; 2015 Feb; 91(2):127-33. PubMed ID: 25604900
    [Abstract] [Full Text] [Related]

  • 2. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: II. Clinical effects.
    Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ.
    Contraception; 2015 Feb; 91(2):134-42. PubMed ID: 25496917
    [Abstract] [Full Text] [Related]

  • 3. Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
    Coelingh Bennink HJT, Zimmerman Y, Laan E, Termeer HMM, Appels N, Albert A, Fauser BCJM, Thijssen JHH, van Lunsen RHW.
    Contraception; 2017 Nov; 96(5):322-329. PubMed ID: 27393080
    [Abstract] [Full Text] [Related]

  • 4. The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive.
    Zimmerman Y, Coelingh Bennink HJ, Wouters W, Ebes F, Fauser BC.
    Eur J Contracept Reprod Health Care; 2013 Dec; 18(6):489-500. PubMed ID: 23944295
    [Abstract] [Full Text] [Related]

  • 5. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
    Wiegratz I, Jung-Hoffmann C, Kuhl H.
    Contraception; 1995 Jun; 51(6):341-6. PubMed ID: 7554973
    [Abstract] [Full Text] [Related]

  • 6. The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of dehydroepiandrosterone.
    Zimmerman Y, Wouters W, Coelingh Bennink HJ.
    Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):206-14. PubMed ID: 23550808
    [Abstract] [Full Text] [Related]

  • 7. Changes in androgens during treatment with four low-dose contraceptives.
    Coenen CM, Thomas CM, Borm GF, Hollanders JM, Rolland R.
    Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
    [Abstract] [Full Text] [Related]

  • 8. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R, Reinilä M, Kivinén S.
    Acta Derm Venereol; 1986 Mar; 66(3):225-30. PubMed ID: 2426899
    [Abstract] [Full Text] [Related]

  • 9. Maintaining physiologic testosterone levels during combined oral contraceptives by adding dehydroepiandrosterone: II. Effects on sexual function. A phase II randomized, double-blind, placebo-controlled study.
    van Lunsen RHW, Zimmerman Y, Coelingh Bennink HJT, Termeer HMM, Appels N, Fauser BCJM, Laan E.
    Contraception; 2018 Jul; 98(1):56-62. PubMed ID: 29490289
    [Abstract] [Full Text] [Related]

  • 10. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
    Oettel M, Carol W, Gräser T, Klinger G, Mellinger U, Moore C, Schindler AE, Winkler UH.
    Zentralbl Gynakol; 1997 Jul; 119(12):597-606. PubMed ID: 9483810
    [Abstract] [Full Text] [Related]

  • 11. Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia.
    Montalto J, Whorwood CB, Funder JW, Yong AB, Callan A, Davies HE, Connelly JF.
    Clin Endocrinol (Oxf); 1990 Jan; 32(1):1-12. PubMed ID: 2139595
    [Abstract] [Full Text] [Related]

  • 12. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Panacea A, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Jan; 21(3):139-41. PubMed ID: 2149912
    [Abstract] [Full Text] [Related]

  • 13. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A, Dewailly SD, Grenier R, Huard J.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [Abstract] [Full Text] [Related]

  • 14. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
    Lello S, Primavera G, Colonna L, Vittori G, Guardianelli F, Sorge R, Raskovic D.
    Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
    Douxfils J, Klipping C, Duijkers I, Kinet V, Mawet M, Maillard C, Jost M, Rosing J, Foidart JM.
    Contraception; 2020 Dec; 102(6):396-402. PubMed ID: 32956694
    [Abstract] [Full Text] [Related]

  • 16. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
    van Vloten WA, van Haselen CW, van Zuuren EJ, Gerlinger C, Heithecker R.
    Cutis; 2002 Apr; 69(4 Suppl):2-15. PubMed ID: 12096825
    [Abstract] [Full Text] [Related]

  • 17. Effect of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) on serum androgen markers in normal-weight, obese, and extremely obese women.
    Segall-Gutierrez P, Du J, Niu C, Ge M, Tilley I, Mizraji K, Stanczyk FZ.
    Contraception; 2012 Dec; 86(6):739-45. PubMed ID: 22959905
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome.
    Morgante G, Cappelli V, Troìa L, De Leo V.
    Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):176-181. PubMed ID: 32191532
    [Abstract] [Full Text] [Related]

  • 19. Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women.
    Giribela CR, Consolim-Colombo FM, Nisenbaum MG, Moraes TL, Giribela AH, Baracat EC, Melo NR.
    Gynecol Endocrinol; 2015 Jun; 31(11):912-5. PubMed ID: 26172927
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial.
    Koltun W, Lucky AW, Thiboutot D, Niknian M, Sampson-Landers C, Korner P, Marr J.
    Contraception; 2008 Apr; 77(4):249-56. PubMed ID: 18342647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.